Headspace as a guided self-help mindfulness course for depression
| ISRCTN | ISRCTN13895659 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN13895659 |
| Protocol serial number | 35113 |
| Sponsor | Sussex Partnership NHS Foundation Trust |
| Funder | Headspace Meditation Limited |
- Submission date
- 31/07/2017
- Registration date
- 01/09/2017
- Last edited
- 11/10/2023
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
Depression has serious personal and economic consequences. Improving Access to Psychological Therapies (IAPT) is an NHS initiative that aims to improve access to psychological therapies for people experiencing depression and anxiety. People experiencing depression are typically offered cognitive behavioural therapy self-help (CBT-SH) supported by a Psychological Wellbeing Practitioner (PWP). However, completion rates and outcomes for IAPT CBT-SH treatment are disappointing; only around 40% of referrals complete treatment, but 58% of people who complete treatment remain depressed. Mindfulness has been found to be useful to helping depression. It could be helpful as a self-help online as it is low cost and some people may not want to attend group sessions Headspace is a smartphone and online application delivering simple daily activities based on mindfulness practice. It teaches beginners the basic concepts of mindfulness through simple, empirically-supported guided meditations. The aim of this study is to investigate an alternative treatment to CBT-SH in IAPT, specifically, an online/smartphone app mindfulness-based self-help programme.
Who can participate?
Adults aged 18 who have mild or moderate clinical depression.
What does the study involve?
Participants are received 30 sessions of the Headspace programme over eight weeks. This is done for ten minutes per day using a smartphone application. Participants are offered six sessions with a PWP to provide encouragement. The programme will be examined for recruitment, retention, acceptability, and preliminary indicators of potential effectiveness. If Headspace is found to be feasible, this will inform the design of further studies, which may eventually inform decision making about the provision of Headspace in IAPT to benefit patients experiencing moderate depression.
What are the possible benefits and risks of participating?
Participants may benefit from improvements in depression symptoms. There are risks of participants becoming more aware of negative thoughts and feelings through the programme as their become more aware of current and past experiences. The PWP will encourage participants to make a choice about to they respond. Participants will have a regular opportunity to talk with the PWP about their experiences of their allocated intervention and the PWP will be supervised by the study lead who is a clinical psychologist with many years of experience in working in mental health care settings. In the event of a participant experiencing a high degree of distress the research team would follow good practice and ensure that the participant is referred on to an appropriate source of support.
Where is the study run from?
1. Croydon IAPT (UK)
2. Brighton and Hove Wellbeing Service (UK)
When is the study starting and how long is it expected to run for?
September 2017 to August 2018
Who is funding the study?
Headspace Meditation Limited (UK)
Who is the main contact?
Dr Clara Strauss
clara.strauss@nhs.net
Contact information
Public
Sussex Education Centre
Mill View Hospital
Nevill Avenue
Hove
BN3 7HY
United Kingdom
| 0000-0002-0303-763X |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Non-randomised; Interventional; Design type: Treatment, Education or Self-Management, Psychological & Behavioural |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Headspace as a PWP-guided online self-help mindfulness intervention for depressive symptoms in IAPT: A feasibility study |
| Study objectives | This is a feasibility study, which aims to address the following questions: 1) Recruitment: Can we recruit? a. How many people are offered the study over the nine-month recruitment period (i.e., people who meet inclusion criteria and are given opportunity to take part)? b. Of (1a), how many people consent to take part in the study? What is this as a percentage of people offered the study (1a)? c. What are the reasons for people declining to take part in the study? d. What is the demographic profile of people consenting/declining to take part (gender, age, ethnicity)? 2) Retention: Can we retain people to the intervention? a. How many people complete the intervention (defined as listening to the guided mindfulness practices on at least 24 sessions of the 30 sessions within 8 weeks)? What is this as a percentage of those consented to take part? b. What are reasons for dropping out of the intervention? c. How many telephone support sessions with a psychological wellbeing practitioner (PWP) are attended on average out of the 6 sessions offered? d. How many people attend at least 3 PWP sessions? What is this as a percentage of those consenting? 3) Acceptability: Is the intervention acceptable? a. How do participants experience the intervention? What aspects of the intervention do participants find helpful and engaging? What aspects of the intervention do participants find unhelpful or act as barriers to engagement? What are short-term and lasting positive and negative effects of practising mindfulness using Headspace? b. How do PWPs experience the intervention? What aspects of the intervention do PWPs find helpful and engaging? What aspects of the intervention do PWPs find unhelpful or act as barriers to engagement? c. How do IAPT service leads/managers experience the intervention? What do IAPT service leads/managers see as the barriers and enablers to implementing the intervention in the service more fully? 4) Effectiveness: What are preliminary indictors of effectiveness? a. What are the pre-post effect sizes on the primary outcome measure of depression symptom severity (PHQ-9)? How do these effect sizes compare to pre-post outcomes in trials of comparable interventions for depression (i.e. guided CBT-SH)? b. What are the pre-post effect sizes on secondary outcomes measures? How do these effect sizes compare to pre-post outcomes in trials of comparable interventions for depression (i.e. guided CBT-SH)? c. What are the pre-post effect sizes on measures of proposed mechanisms? How do these effect sizes compare to pre-post outcomes in trials of comparable interventions for depression (i.e. guided CBT-SH)? |
| Ethics approval(s) | London - Surrey Borders Research Ethics Committee, 06/07/2017, ref: 17/LO/1032 |
| Health condition(s) or problem(s) studied | Specialty: Mental Health, Primary sub-specialty: Depression; UKCRC code/ Disease: Mental Health/ Mood [affective] disorders |
| Intervention | This is a feasibility study examining recruitment, retention, acceptability, and preliminary indicators of effectiveness to/of Headspace as a PWP-guided self-help intervention for depressive symptoms in IAPT. Intervention Participants are offered the 30-session foundation course of the Headspace programme (www.headspace.com) and asked to engage with this over eight weeks. Headspace is a smartphone and online application delivering simple daily activities based on mindfulness practice. It teaches beginners the basic concepts of mindfulness through simple, empirically-supported guided meditations. The 30-session course invites participants to spend at least 10 minutes per day over 8 weeks practising guided meditations. If participants complete all 30 sessions before the end of 8 weeks, and before their final support session with the mental health practitioner, they are instructed to repeat any sessions from the foundation course or select one of the other packs from Headspace that seems most helpful to them. As is routine at Step 2 in IAPT, participants are also be offered six PWP sessions, delivered by telephone or in person, to answer questions and provide encouragement. This intervention procedure therefore mirrors the usual way in which interventions are offered at Step 2 in IAPT; offering a self-help workbook alongside a limited number of PWP support sessions. The purpose of using outcome measures in feasibility studies is to investigate and evaluate a number of processes related to the intervention (intervention recruitment, retention, acceptability and preliminary indicators of effectiveness), rather than outcomes related to the effectiveness of the intervention. As such, feasibility studies need not include a primary outcome measure. Qualitative data regarding participants’ experience of the interventions (e.g., helpful and unhelpful aspects of the intervention) will be collected through telephone interviews conducted after the end of the intervention by the RA with the first 10 participants opting in to this optional part of the study. The topic guide for the post-intervention telephone interviews will be based on the Change Interview (Elliott et al., 2001). The change interview is a semi-structured questionnaire designed to ask participants about any changes that occurred in their lives since starting the intervention and their attributions of these changes. Change can be attributed to the intervention or to external factors. Participants are also asked to comment on those aspects of the intervention that facilitated change, and those that may have hindered it. Each interview will take approximately 30-45 minutes, will take place over the phone, and will be audio recorded to aid transcription and data analysis. |
| Intervention type | Other |
| Primary outcome measure(s) |
The purpose of using outcome measures in feasibility studies is to investigate and evaluate a number of processes related to the intervention (intervention recruitment, retention, acceptability and preliminary indicators of effectiveness), rather than outcomes related to the effectiveness of the intervention. As such, feasibility studies need not include a primary outcome measure. |
| Key secondary outcome measure(s) |
No secondary outcome measures. |
| Completion date | 31/08/2018 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 50 |
| Key inclusion criteria | 1. Adults aged 18+ years 2. Current service users at the participating services 3. Score 10-19 on the PHQ-9 (indicating mild or moderate clinical depression) at assessment in the service 4. Regular personal access to a smartphone, computer, or tablet with internet access to use Headspace 5. Sufficient literacy skills to read and understand self-help materials |
| Key exclusion criteria | 1. Currently receiving a psychological intervention 2. Rated as medium or high risk to self or others on the service risk assessment tool, including risk of self-harm behaviours 3. Substance use associated with significant impairment 4. Meet diagnostic criteria based on the Mini International Neuropsychiatric Interview (MINI version 6.0.0, Sheehan et al, 2010) for a psychotic disorder, post-traumatic stress disorder, or obsessive-compulsive disorder |
| Date of first enrolment | 11/09/2017 |
| Date of final enrolment | 30/06/2018 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centres
Bethlem Royal Hospital
Monks Orchard Road
Kent
Beckenham
BR3 3BX
United Kingdom
177 Preston Road
Brighton
BN1 6AG
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Available on request |
| IPD sharing plan | The datasets generated during the current study will be available upon request from Clara Strauss (clara.strauss@nhs.net) following publication of the main trial findings. Data will be shared with other research teams for the purpose of contributing to systematic reviews and meta-analyses. Participant consent has been sought for this. Shared data will be fully anonymised. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | 01/09/2021 | 11/10/2023 | Yes | No | |
| HRA research summary | 28/06/2023 | No | No | ||
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
11/10/2023: Publication reference added.